Actively Recruiting
AI-Based Personalized Nutritional Plans for Managing Chemotherapy-Related Taste Disorders in Cancer Patients Using the Gustabor Web Platform
Led by Wuerzburg University Hospital · Updated on 2026-08-21
51
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating taste disorders that often occur during or after cancer treatments like chemotherapy, which can lead to problems such as malnutrition and stopping treatment early. This pilot study aims to evaluate an AI-based system that creates personalized dietary recommendations to help patients manage these taste changes. The study focuses on patients with multiple myeloma or gastrointestinal cancers who experience taste disorders related to their cancer therapy. Participants will use the Gustabor server, an AI-based web platform that generates lifestyle tips and recipe suggestions tailored to each patients taste impairments and preferences. The AI is trained on recipes and uses patient data to recommend foods likely to be better tolerated, including specific advice such as favoring cold meals for metallic taste. Participants will receive printed recommendations and general dietary advice flyers. The study lasts up to 12 weeks and includes at least two clinical visits spaced by a minimum of three weeks. During the study, participants will provide information on their eating habits, taste experiences, and taste thresholds for sweet, sour, salty, bitter, and umami flavors through questionnaires and taste strip tests. Researchers will assess nutritional status using the Patient-Generated Subjective Global Assessment PG-SGA at the start and end of the study. The main measure is how helpful participants find the nutritional advice at the second visit within 12 weeks. Additional outcomes include identifying which recommendations were most useful and exploring links between taste perception, tumor type, and ongoing therapy.
CONDITIONS
Brief Title
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
Research Team
A
Alexander Hann, Prof. Dr. med.
A
Anna Fleischer, Dr. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here